Testing effectiveness (Phase 2)Study completedNCT00005629What this trial is testingVaccine Therapy in Treating Patients With Liver CancerWho this might be right forLiver Cancer Jonsson Comprehensive Cancer Center 6
Testing effectiveness (Phase 2)Study completedNCT00024258What this trial is testingArsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid TumorsWho this might be right forBrain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+6 more Memorial Sloan Kettering Cancer Center 22
Early research (Phase 1)Study completedNCT00467194What this trial is testingSirolimus and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed by SurgeryWho this might be right forLiver Cancer National Cancer Centre, Singapore 27
Testing effectiveness (Phase 2)Study completedNCT00875615What this trial is testingCisplatin or Carboplatin and Sorafenib in Treating Patients With Liver Cancer That Cannot Be Removed By SurgeryWho this might be right forLiver Cancer University of Miami 11
Testing effectiveness (Phase 2)Study completedNCT01010126What this trial is testingTemsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell CancerWho this might be right forAdult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaEndometrial Serous Adenocarcinoma+42 more National Cancer Institute (NCI) 252
Early research (Phase 1)Study completedNCT01042041What this trial is testingSorafenib Tosylate and Chemoembolization in Treating Patients With Unresectable Liver CancerWho this might be right forHepatocellular CarcinomaLiver CancerLocalized Unresectable Liver Cancer Abramson Cancer Center at Penn Medicine 18
Testing effectiveness (Phase 2)Study completedNCT01624285What this trial is testingSorafenib Tosylate Following a Liver Transplant in Treating Patients With Liver CancerWho this might be right forAdult Primary Hepatocellular CarcinomaLocalized Resectable Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more Jonsson Comprehensive Cancer Center 20
Testing effectiveness (Phase 2)UnknownNCT00276705What this trial is testingCombination Chemotherapy and Thalidomide in Treating Younger Patients Undergoing Surgery For Newly Diagnosed Liver CancerWho this might be right forLiver Cancer Children's Cancer and Leukaemia Group 47
Testing effectiveness (Phase 2)Study completedNCT00057980What this trial is testingEpirubicin and Celecoxib in Treating Patients With Hepatocellular CarcinomaWho this might be right forLiver Cancer Northwestern University 8
Testing effectiveness (Phase 2)Study completedNCT00019786What this trial is testingIsolated Hepatic Perfusion With Melphalan in Treating Patients With Primary Unresectable Liver Cancer or Liver MetastasesWho this might be right forColorectal CancerIslet Cell TumorLiver Cancer+2 more National Institutes of Health Clinical Center (CC) 67
Early research (Phase 1)Study completedNCT00654160What this trial is testingIrinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal CancerWho this might be right forAnal CancerCarcinoma of the AppendixColorectal Cancer+9 more Mayo Clinic 7
Early research (Phase 1)Study completedNCT00608361What this trial is testingDasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By SurgeryWho this might be right forAdult Acute Lymphoblastic Leukemia in RemissionAdult B Acute Lymphoblastic LeukemiaAdult Hepatocellular Carcinoma+82 more National Cancer Institute (NCI) 80
Early research (Phase 1)Study completedNCT00161187What this trial is testingIrradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid TumorWho this might be right forCancer University of Medicine and Dentistry of New Jersey 37
Early research (Phase 1)Study completedNCT00030082What this trial is testingHepatic Arterial Infusion With Melphalan in Treating Patients With Unresectable Liver CancerWho this might be right forLiver CancerMetastatic Cancer National Cancer Institute (NCI)
Early research (Phase 1)Ended earlyNCT00767468What this trial is testingSorafenib in Treating Patients With Locally Advanced or Metastatic Liver Cancer and CirrhosisWho this might be right forLiver Cancer UNC Lineberger Comprehensive Cancer Center 6
Testing effectiveness (Phase 2)Ended earlyNCT00023946What this trial is testingBMS-247550 in Treating Patients With Liver or Gallbladder CancerWho this might be right forAdult Primary Cholangiocellular CarcinomaAdult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver Cancer+11 more National Cancer Institute (NCI) 50
Testing effectiveness (Phase 2)Ended earlyNCT00427973What this trial is testingAZD2171 in Treating Patients With Locally Advanced Unresectable or Metastatic Liver CancerWho this might be right forAdult Primary Hepatocellular CarcinomaAdvanced Adult Primary Liver CancerLocalized Unresectable Adult Primary Liver Cancer+1 more National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Study completedNCT00047229What this trial is testingOblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)Who this might be right forLiver Cancer University Health Network, Toronto 27
Not applicableEnded earlyNCT00087191What this trial is testingEF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal or Non-Small Cell Lung CancerWho this might be right forAdvanced Adult Primary Liver CancerCarcinoma of the AppendixFallopian Tube Cancer+68 more National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT00486356What this trial is testingCapecitabine, Epirubicin, and Carboplatin in Treating Patients With Progressive, Unresectable, or Metastatic CancerWho this might be right forExtrahepatic Bile Duct CancerGallbladder CancerGastric Cancer+2 more University of Nebraska 46